Ashley Swagerty, PA
Physician Assistant · Owosso, MINPI 1932731775
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 1,427 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,089, 2.4 times the $2,491 reported in 2021. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,427 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Neurocrine Biosciences, Inc.$1K
- plus $7K from 20 others
What the payments were for
- Food & beverage$19,26799%
- Education$2251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 171 | $2,497 |
| AbbVie | 194 | $2,327 |
| Teva Pharmaceuticals USA, Inc. | 174 | $2,195 |
| Alkermes, Inc. | 109 | $1,960 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 137 | $1,793 |
| Neurocrine Biosciences, Inc. | 111 | $1,383 |
| Johnson & Johnson | 88 | $1,226 |
| Lundbeck LLC | 73 | $1,106 |
| Axsome Therapeutics, Inc. | 48 | $916 |
| Sunovion Pharmaceuticals Inc. | 98 | $751 |
| Takeda Pharmaceuticals U.S.A., Inc. | 40 | $676 |
| Vanda Pharmaceuticals Inc. | 40 | $636 |
| Supernus Pharmaceuticals, Inc. | 44 | $547 |
| Corium, LLC | 40 | $544 |
| E.r. Squibb & Sons, L.L.C. | 19 | $245 |
| Validus Pharmaceuticals LLC | 10 | $157 |
| Collegium Pharmaceutical, Inc. | 8 | $147 |
| Idorsia Pharmaceuticals US Inc | 8 | $137 |
| Ironshore Pharmaceuticals Inc. | 4 | $83 |
| Avanir Pharmaceuticals, Inc. | 3 | $53 |
| Almatica Pharma LLC | 2 | $38 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Neos Therapeutics, LP | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Brainsway USA Inc | 1 | $12 |
| Sumitomo Pharma America, Inc. | 2 | $11 |
How this compares
$19,492 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physician assistant in Owosso
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.